Skip to main content


You are here

August 2017 Archive

Gliknik Announces Dosing of First Patient in Phase 2 Trial Targeting Prevention of Recurrence of High-Risk Oral Cavity Cancer

Gliknik Inc. today announced that clinicians have enrolled and dosed the first of 80 patients in the company’s phase 2 clinical trial.

Global University Venturing - USM Gains Momentum with Wise

Read an article about USM gaining momentum via Global University Venturing. Baltimore: David Wise Named Director of University System of Maryland’s Early-Stage Investment Fund

The University System of Maryland was recently named a leader for its early stage investment fund that is seeking to back early-stage startups.